当前位置：首页 SCI 期刊医学 Neoplasia(非官网)

NeoplasiaSCIE

国际简称：NEOPLASIA 参考译名：瘤形成

中科院分区
2区
CiteScore分区
Q2
JCR分区
Q1

基本信息：: ISSN：1476-5586; E-ISSN：1476-5586; 是否OA：开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：UNITED STATES; 出版商：Neoplasia Press; 出版语言：English; 出版周期：Monthly; 出版年份：1999; 研究方向：ONCOLOGY

评价信息：: 影响因子：6.3; H-index：115; CiteScore指数：9.2; SJR指数：1.887; SNIP指数：1.225

发文数据：: Gold OA文章占比：98.62%; 研究类文章占比：94.87%; 年发文量：78; 自引率：0.0208...; 开源占比：0.9596; 出版撤稿占比：0; 出版国人文章占比：0.17; OA被引用占比：1

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Neoplasia期刊介绍

Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.

期刊简介Neoplasia期刊介绍

《Neoplasia》自1999出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 12 Weeks
国际TOP期刊
医学
ONCOLOGY
SCIE
中科院2区
非预警

Cite Score数据（2024年最新版）Neoplasia Cite Score数据

CiteScore：9.2
SJR：1.887
SNIP：1.225

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Cancer Research	Q2	60 / 230	74%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Neoplasia 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	2区	ONCOLOGY 肿瘤学	2区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Neoplasia JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	48 / 322	85.2%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	45 / 322	86.18%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA132
CHINA MAINLAND68
GERMANY (FED REP GER)28
Japan15
Canada13
Taiwan13
England12
Italy12
Switzerland12
Australia11

本刊中国学者近年发表论文

1、FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer
Author: Tang, Qingyun; Liu, Cheng; Zhang, Shengwei; He, Lijiao; Liu, Yunyi; Wang, Jing; Zhao, Xiaoyan; Li, Xinzhe

Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100863
2、Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model
Author: Wang, Jie; Sud, Shivani; Qu, Yanli; Li, Liantao; Zhang, Jiajie; Marron, David; Knape, Nicole Michelle; Kim, Isaiah James; Wagner, Kyle Thomas; Zhang, Tian; Zhao, Yuxia; Guo, Genyan; Wang, Andrew Z.

Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100864
3、The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science
Author: Lilly, Jena, V; Rokita, Jo Lynne; Mason, Jennifer L.; Patton, Tatiana; Stefankiewiz, Stephanie; Higgins, David; Trooskin, Gerri; Larouci, Carina A.; Arya, Kamnaa; Appert, Elizabeth; Heath, Allison P.; Zhu, Yuankun; Brown, Miguel A.; Zhang, Bo; Farrow, Bailey K.; Robins, Shannon; Morgan, Allison M.; Nguyen, Thinh Q.; Frenkel, Elizabeth; Lehmann, Kaitlin; Drake, Emily; Sullivan, Catherine; Plisiewicz, Alexa; Coleman, Noel; Patterson, Luke; Koptyra, Mateusz; Helili, Zeinab; Van Kuren, Nicholas; Young, Nathan; Kim, Meen Chul; Friedman, Christopher; Lubneuski, Alex; Blackden, Christopher; Williams, Marti; Baubet, Valerie; Tauhid, Lamiya; Galanaugh, Jamie; Boucher, Katie; Ijaz, Heba; Cole, Kristina A.; Choudhari, Namrata; Santi, Mariarita; Moulder, Robert W.; Waller, Jonathan; Rife, Whitney; Diskin, Sharon J.; Mateos, Marion; Parsons, Donald W.; Pollack, Ian F.; Goldman, Stewart; Leary, Sarah; Caporalini, Chiara; Buccoliero, Anna Maria; Scagnet, Mirko; Haussler, David; Hanson, Derek; Firestein, Ron; Cain, Jason; Phillips, Joanna J.; Gupta, Nalin; Mueller, Sabine; Grant, Gerald; Monje-Deisseroth, Michelle; Partap, Sonia; Greenfield, Jeffrey P.; Hashizume, Rintaro; Smith, Amy; Zhu, Shida; Johnston, James M.; Fangusaro, Jason R.; Miller, Matthew; Wood, Matthew D.; Gardner, Sharon; Carter, Claire L.; Prolo, Laura M.; Pisapia, Jared; Pehlivan, Katherine; Franson, Andrea; Niazi, Toba; Rubin, Josh; Abdelbaki, Mohamed; Ziegler, David S.; Lindsay, Holly B.; Stucklin, Ana Guerreiro; Gerber, Nicolas; Vaske, Olena M.; Quinsey, Carolyn; Rood, Brian R.; Nazarian, Javad; Raabe, Eric; Jackson, Eric M.; Stapleton, Stacie; Lober, Robert M.; Kram, David E.; Koschmann, Carl; Storm, Phillip B.; Lulla, Rishi R.; Prados, Michael; Resnick, Adam C.; Waanders, Angela J.

Journal: NEOPLASIA. 2023; Vol. 35, Issue , pp. -. DOI: 10.1016/j.neo.2022.100846
4、Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer
Author: Gao, Yaqi; Zou, Tianhui; Xu, Pingping; Wang, Yingchao; Jiang, Yi; Chen, Ying-Xuan; Chen, Haoyan; Hong, Jie; Fang, Jing-Yuan

Journal: NEOPLASIA. 2023; Vol. 35, Issue , pp. -. DOI: 10.1016/j.neo.2022.100850
5、A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity
Author: Wang, Xueli; Han, Bo; Dou, Baokai; Gao, Lin; Sun, Feifei; Qi, Mei; Zhang, Jing; Hu, Jing

Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100875
6、Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients-Knowledge from two independent international studies
Author: Zhou, Jian-Guo; Liang, Rui; Wang, Hai-Tao; Jing, Su-Han; Hu, Wei; Frey, Benjamin; Fietkau, Rainer; Hechth, Markus; Ma, Hu; Gaipl, Udo S.

Journal: NEOPLASIA. 2023; Vol. 37, Issue , pp. -. DOI: 10.1016/j.neo.2023.100877
7、Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors
Author: Bai, Yongkan; Liu, Xiang; Zheng, Limin; Wang, Song; Zhang, Junli; Xiong, Shi; Zhang, Pengfei; Jiao, Zichen; Zhao, Gefei; Zhou, Chu; Pang, Jiaohui; Xu, Yang; Ou, Qiuxiang; Mao, Yuan; Zhang, Louqian

Journal: NEOPLASIA. 2023; Vol. 38, Issue , pp. -. DOI: 10.1016/j.neo.2023.100888
8、Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells
Author: Shui, Yifang; Hu, Xin; Hirano, Hiroshi; Tsukamoto, Hirotake; Guo, Wen-Zhi; Hasumif, Kenichiro; Ijima, Fumihiro; Fujino, Masayuki; Li, Xiao-Kang

Journal: NEOPLASIA. 2023; Vol. 39, Issue , pp. -. DOI: 10.1016/j.neo.2023.100893